Babag, Arriane B.

HRN: 26-00-07  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2024
CEFUROXIME 1.5GM (VIAL)
10/10/2024
10/17/2024
IV
600mg
Q8h
UTI
Waiting Final Action 
10/13/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
10/13/2024
10/17/2024
PO
5ml
BID
UTI
Waiting Final Action 
10/13/2024
MUPIROCIN 2%, 15G (TUBE)
10/13/2024
10/20/2024
TOPICAL
As Needed
TID
Phlebitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: